Telemedical care and quality of life in patients with schizophrenia and bipolar disorder: results of a randomized controlled trial
| Autor: | Wolfgang Hoffmann, Kilson Moon, Hans J. Grabe, Jens M. Langosch, Neeltje van den Berg, Lara N. Schulze, Josephine Schulte, Ulrike Stentzel |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male Quality of life medicine.medical_specialty Telemedicine Bipolar Disorder RC435-571 law.invention Social support Randomized controlled trial law medicine Humans Bipolar disorder Prospective Studies Disease burden Psychiatry Telemedical care business.industry medicine.disease humanities WHOQOL-BREF Clinical trial Psychiatry and Mental health Schizophrenia Physical therapy Female business Research Article |
| Zdroj: | BMC Psychiatry BMC Psychiatry, Vol 21, Iss 1, Pp 1-14 (2021) |
| ISSN: | 1471-244X |
| Popis: | BackgroundSchizophrenia and bipolar disorder are serious psychiatric disorders with a high disease burden, a high number of years of life lived with disability and a high risk for relapses and re-hospitalizations. Besides, both diseases are often accompanied with a reduced quality of life (QoL). A low level of quality of life is one predictor for relapses. This study examines whether a telemedical care program can improve QoL.MethodsPost stationarytelemedicalcare of patients with severe psychiatric disorders” (Tecla) is a prospective controlled randomized intervention trial to implement and evaluate a telemedical care concept for patients with schizophrenia and bipolar disorder. Participants were randomized to an intervention or a control group. The intervention group received telemedical care including regular, individualized telephone calls and SMS-messages. QoL was measured with the German version of the WHOQOL-BREF. Effects of telemedicine on QoL after 6 months and treatment*time interactions were calculated using linear regressions (GLM and linear mixed models).ResultsOne hundred eighteen participants were recruited, thereof 57.6% men (n = 68). Participants were on average 43 years old (SD 13). The treatment*time interaction was not significant. Hence, treatment had no significant effect either. Instead, gender is an influencing factor. Further analysis showed that social support, the GAF-level and QoL-values at baselines were significant determinants for the improvement of QoL.ConclusionThe telemedicine care concept Tecla was not significant for QoL in patients with severe psychiatric disorders. More important for the QoL is the general social support and the level of global functioning of the patients.Trial registrationGerman Clinical Trials Register, DRKS00008548, registered 21 May 2015 – retrospectively registered,https://www.drks.de/drks_web/setLocale_EN.do |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink